comparemela.com
Home
Live Updates
Phase 3 Data on Bimekizumab for Hidradenitis Suppurativa Show Meaningful Improvements : comparemela.com
Phase 3 Data on Bimekizumab for Hidradenitis Suppurativa Show Meaningful Improvements
The findings from these 2 trials for bimekizumab may lead to greater treatment options for patients with HS, an often debilitating and chronic skin condition.
Related Keywords
Berlin ,
Germany ,
United States ,
American ,
Hidradenitis Suppurativa ,
European Hidradenitis Suppurativa Foundation ,
Brandenburg Medical School ,
American Academy Of Dermatology ,
European Academy Of Dermatology ,
Analysis Presented ,
Bimekizumab Achieved High Thresholds ,
Clinical Response ,
American Academy ,
Dhs ,
Bimekizumab ,
Phase 3 ,
comparemela.com © 2020. All Rights Reserved.